Withdrawal symptoms of trifluoperazine.
Chakraborty
Rudraprosad
R
Chatterjee
Arunima
A
Chaudhury
Suprakash
S
D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000523:psychology*; D014268:Trifluoperazine / Q000009:adverse effects* / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D015283:Citalopram; D014268:Trifluoperazine